LMNX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide...

Stats
Dzisiejszy wolumen	1.02M
Średni wolumen	650 237
Kapitalizacja rynkowa	0.00
EPS	$0 ( 2021-08-02 )
Last Dividend	$0.100 ( 2021-06-16 )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.188 (0.51%)

Insider Trading

Date	Person	Action	Amount	type
2021-07-14	Ogunro Edward A	Sell	10 760	Common Stock
2021-07-14	Ogunro Edward A	Sell	50 133	Common Stock
2021-07-14	Mcnamara Kevin M	Sell	24 443	Common Stock
2021-07-14	Mcnamara Kevin M	Sell	75 925	Common Stock
2021-07-14	Erickson Thomas W	Sell	79 204	Common Stock

INSIDER POWER
0.00
Last 100 transactions
Buy: 1 457 367 \| Sell: 3 933 642

Wolumen Korelacja

Długi: 0.06 (neutral)

Krótki: 0.88 (strong)

Signal:(63.839) Same movement expected

Luminex Corporation Korelacja

10 Najbardziej pozytywne korelacje
SUMO	0.955
FFNW	0.941
DSPG	0.935
TAST	0.926
CCRC	0.923
HCCI	0.917
ISRG	0.915
CLST	0.913
EAR	0.913
MRTX	0.912

10 Najbardziej negatywne korelacje
ATHX	-0.945
VRAY	-0.94
ODT	-0.927
DCGO	-0.926
RNAZ	-0.926
UXIN	-0.923
TCDA	-0.921
SNAX	-0.918
XPDI	-0.911
EYEG	-0.91

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Luminex Corporation Korelacja - Waluta/Towar

0.31
( neutral )

-0.24
( neutral )

-0.68
( moderate negative )

-0.27
( neutral )

-0.13
( neutral )

0.81
( strong )

Luminex Corporation Finanse

Annual	2020
Przychody:	$417.40M
Zysk brutto:	$247.85M (59.38 %)
EPS:	$0.336

FY	2020
Przychody:	$417.40M
Zysk brutto:	$247.85M (59.38 %)
EPS:	$0.336

FY	2019
Przychody:	$334.64M
Zysk brutto:	$182.74M (54.61 %)
EPS:	$-0.0900

FY	2018
Przychody:	$315.82M
Zysk brutto:	$195.49M (61.90 %)
EPS:	$0.420

Financial Reports:

No articles found.

Luminex Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Luminex Corporation Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.83 - No dividend growth expected in the near future

Information

First Dividend	$0.0600	2017-03-22
Last Dividend	$0.100	2021-06-16
Next Dividend	$0	N/A
Payout Date	2021-07-08
Next Payout Date	N/A
# dividends	18	--
Total Paid Out	$1.350	--
Avg. Dividend % Per Year	0.22%	--
Score	4.31	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.83
Div. Directional Score	8.48	--

Next Divdend (Est)
(2024-06-27)

$0 Estimate 0.00 %

Dividend Stability

0.14 Bad

Dividend Score

4.31

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2017	$0.240	1.18%
2018	$0.240	1.18%
2019	$0.300	1.32%
2020	$0.370	1.61%
2021	$0.200	0.82%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0363	1.500	9.27	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0197	1.200	9.34	10.00	[0 - 0.3]
returnOnEquityTTM	0.0309	1.500	-0.768	-1.152	[0.1 - 1]
payoutRatioTTM	1.087	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	5.82	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.30	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	3.54	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.271	-1.500	5.48	-8.21	[0 - 0.6]
interestCoverageTTM	3.56	1.000	9.79	9.79	[3 - 30]
operatingCashFlowPerShareTTM	1.090	2.00	9.64	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.699	2.00	9.65	10.00	[0 - 20]
debtEquityRatioTTM	0.404	-1.500	8.38	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.594	1.000	3.44	3.44	[0.2 - 0.8]
operatingProfitMarginTTM	0.102	1.000	9.97	9.97	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.239	1.000	9.78	9.78	[0.2 - 2]
assetTurnoverTTM	0.542	0.800	9.72	7.78	[0.5 - 2]
Total Score				13.13

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	111.73	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.0309	2.50	-0.494	-1.152	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.699	2.00	9.77	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.090	2.00	9.64	10.00	[0 - 30]
payoutRatioTTM	1.087	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-17.50	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.120	1.000	9.51	0	[0.1 - 0.5]
Total Score				3.83

Luminex Corporation

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.